| Product Code: ETC11530798 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Companion Diagnostic Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Companion Diagnostic Market - Industry Life Cycle |
3.4 Taiwan Companion Diagnostic Market - Porter's Five Forces |
3.5 Taiwan Companion Diagnostic Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Taiwan Companion Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Taiwan Companion Diagnostic Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Taiwan Companion Diagnostic Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Taiwan Companion Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Taiwan Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Taiwan, leading to higher demand for companion diagnostics |
4.2.2 Technological advancements in precision medicine driving the adoption of companion diagnostics |
4.2.3 Growing focus on personalized healthcare and targeted therapies in Taiwan |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for companion diagnostics in Taiwan |
4.3.2 Limited awareness and understanding among healthcare providers and patients about companion diagnostics |
5 Taiwan Companion Diagnostic Market Trends |
6 Taiwan Companion Diagnostic Market, By Types |
6.1 Taiwan Companion Diagnostic Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Companion Diagnostic Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Taiwan Companion Diagnostic Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Taiwan Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.1.5 Taiwan Companion Diagnostic Market Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031F |
6.1.6 Taiwan Companion Diagnostic Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.2 Taiwan Companion Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Companion Diagnostic Market Revenues & Volume, By Drug Response Testing, 2021 - 2031F |
6.2.3 Taiwan Companion Diagnostic Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.2.4 Taiwan Companion Diagnostic Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.5 Taiwan Companion Diagnostic Market Revenues & Volume, By Disease Identification, 2021 - 2031F |
6.3 Taiwan Companion Diagnostic Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Companion Diagnostic Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Taiwan Companion Diagnostic Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.4 Taiwan Companion Diagnostic Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Taiwan Companion Diagnostic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4 Taiwan Companion Diagnostic Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Companion Diagnostic Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Taiwan Companion Diagnostic Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Taiwan Companion Diagnostic Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Taiwan Companion Diagnostic Market Revenues & Volume, By Urine, 2021 - 2031F |
6.5 Taiwan Companion Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Companion Diagnostic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Taiwan Companion Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5.4 Taiwan Companion Diagnostic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Taiwan Companion Diagnostic Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 Taiwan Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Taiwan Companion Diagnostic Market Export to Major Countries |
7.2 Taiwan Companion Diagnostic Market Imports from Major Countries |
8 Taiwan Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics by healthcare facilities in Taiwan |
8.2 Number of partnerships between diagnostic companies and pharmaceutical companies for companion diagnostic development |
8.3 Percentage of healthcare professionals trained in the use of companion diagnostics |
9 Taiwan Companion Diagnostic Market - Opportunity Assessment |
9.1 Taiwan Companion Diagnostic Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Taiwan Companion Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Taiwan Companion Diagnostic Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.4 Taiwan Companion Diagnostic Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Taiwan Companion Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Taiwan Companion Diagnostic Market - Competitive Landscape |
10.1 Taiwan Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here